Tandem Diabetes Care Inc. reported that its next-generation automated insulin delivery algorithm, Control-IQ+ technology (Control-IQ+), is cleared by the U.S. FDA for use by people with type 2 ...

HYDERABAD Feb 25 (Reuters) - Medical device maker Medtronic (MDT.N), opens new tab is looking at options to modify its global manufacturing footprint as part of efforts to mitigate any impact of U ...

Medtronic is a diversified medical device maker with a global footprint. Its reliably growing dividend has helped fuel its stock performance for decades. Its shares are reasonably valued for the ...

The study evaluated 24 adult participants with type 1 diabetes mellitus. They wore one sensor of each CGM system in parallel for up to 15 days. Participants exchanged sensors for G7 and Simplera on ...

A clinician uses Medtronic's pulsed field ablation system for treating atrial fibrillation last month. On Tuesday, Medtronic reported adjusted quarterly net profit of $1.8 billion on $8.3 billion ...

Medtronic posted a strong profit for Q3 of fiscal ... its customer base and strengthened its continuous glucose monitor (CGM) attachment rates, as per the earnings release.

Medtronic missed Wall Street's fiscal 2025 Q3 revenue estimate but beat earnings expectations. The company's revenue miss appears to be primarily related to a temporary change in distributor ...

Actual results may differ materially from anticipated results. Medtronic does not undertake to update its forward-looking statements or any of the information contained in this press release ...

CMA CGM has unveiled plans to deepen ties with India, days after talks with Prime Minister Narendra Modi. The French container line is pledging its support for a new maritime corridor linking ...